Dr. James Abram McBride, MD

Dr. McBride practices at Colorado Springs Urological Associates in Colorado Springs, Colorado.

Dr. McBride's NPI, 1891057923, was assigned on June 14, 2012. Dr. McBride graduated from Eastern Virginia Medical School in 2012. Dr. McBride holds Colorado license DR.0060502.

Dr. McBride's primary practice is Colorado Springs Urological Associates, at 1644 Medical Center Pt, Colorado Springs, CO 80907 in El Paso County. The practice phone is (719) 531-7007.

Dr. McBride's primary practice is Colorado Springs Urological Associates in Colorado Springs, Colorado. Dr. McBride is also affiliated with CommonSpirit - Penrose Hospital. The medical group on file is Colorado Springs Urology. Dmand AI also links Dr. McBride to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McBride practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. McBride's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. McBride is licensed in Colorado.

CMS data shows 1,283 Medicare services from Dr. McBride across 21 procedure codes in 2024, for 285 Medicare patients. Medicare paid $77,579 for them.

CMS counts 285 Medicare patients who saw Dr. McBride in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McBride's median patient age at 54, with 3% women.

In 2024, Dr. McBride wrote 1,186 Medicare Part D claims for 329 patients. 90% of them were for generic drugs. CMS names the drug for 1,075 of them, across 21 drugs with 11 or more claims each, at $111,015 in total drug cost. In 2023, CMS named 861 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. McBride for performance year 2024, reported as part of a group. Dr. McBride accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McBride as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. McBride, published from 2012 to 2020. The most frequent topics are Testosterone, Androgens and Hormone Replacement Therapy. Dr. McBride has published most often in Am J Mens Health. Dr. McBride's most frequent co-authors are Robert Matthew Coward, MD, Larry I. Lipshultz, MD and Nannan Thirumavalavan, MD.

CMS Open Payments shows 621 general payments to Dr. McBride from 56 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Boston Scientific Corporation paid the most, $192,068.

Dr. McBride graduated from Eastern Virginia Medical School in 2012.